About ADx NeuroSciences
ADx NeuroSciences is a collaborative partner at the forefront of neurodegenerative biomarker innovation. Based in Ghent, Belgium, one of Europe’s leading life sciences hubs, we benefit from strong research collaborations and access to top scientific talent. Additionally, we are actively involved in industry consortia, interacting with patient groups, and driving standardization and regulation in the neuro field.
Strengthening Our Mission with Fujirebio Europe
To advance this mission, ADx NeuroSciences is now part of Fujirebio Europe, allowing us to combine our expertise and resources with a leading global diagnostics organization. This collaboration strengthens our ability to translate promising biomarkers into robust, clinically meaningful assays, accelerate research and development, and contribute to potentially important new insights in the neurodegenerative field.
Proven Leadership advancing Biomarker Development
Our management team brings over 45 years of combined experience and a proven track record in developing superior diagnostic biomarkers. Through close partnerships, deep scientific knowledge, and hands-on experience in assay development, ADx NeuroSciences bridges the gap between discovery and clinical application and helps translating research into solutions that can truly improve patient outcomes.